何敏夫 (2001) 血液學。合記圖書出版社,臺北市。
何敏夫 (1999) 臨床化學。合記圖書出版社,臺北市。
廖灼華 (2000) KTC-5、 DS-8 及 chebulanin 對於人類血小板凝集之抑制機轉探討。國立臺灣大學藥理學研究所碩士論文,台北。American Chemical Society: Noni plant may yield new drugs to fight tuberculosis. (2000) Press release the 2000 International Chemical Congress of Pacific Basin Societies.
Bhatt, D.L. and Topol, E.J. (2003) Scientific and therapeutic advances in antiplatelet therapy. Nature Reviews Drug Discovery, 2: 15–28.
Berridge, M.J.and Irvine, R.F. (1989) Inositol phosphates and cell signalling. Nature; 341: 197-205.
Barnes, M.J. and Farndale, R.W. (1999) Collagen and atherosclerosis. Experimental Gerontology, 34: 513-525.
Billah, M.M., Lapetina, E.G. and Cuatrecasas, P. (1981) Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets. J. Biol.Chem., 256: 5399–5403.
Brass, L.F. (2003) Thrombin and platelet activation. Chest, 124: 18–25.
Chao, W. and Olson, M.S. (1993) Platelet-activating factor: receptors and signal transduction. Biochem J, 292: 617-629.
Chen, Y.L., Wang, T.C., Liang, S.C., Teng, C.M. and Tzeng, C.C. (1996) Synthesis and evaluation of coumarin alpha-methylene-gamma-butyrolactone: a new class of platelet aggregation inhibitors. Chem. Pharm. Bull., 44(8): 1591-1595.
Davies, M.J. (2000) The pathophysiology of acute coronary syndromes. Heart, 83: 361–366.
FuMter, V, Gotto, A.M., Llbby, P., Loscaizo, J. and McGill, H.C. (1996) 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force I: pathogenesis of coronary diisease; the biologic roie of risk t'dctors. J Am Coll Cardiol, 27: 964-976.
Fox, J.E.B. and Phillips, D.R. (1982) Role of phosphorylation in mediating the association of myosin with the cytoskeletal structures of human platelets. J Biol Chem, 257: 4120-4126.
Ferguson, J.J., Quinn, M. and Moakc, J.L. (2000) The physiology of normal platelet function. Antiplateiet Therapy in Clinical Practice., 15-34.
Gear, A.R.I. (1994) Platelet adhesion, shape change and aggregation: rapid initiation and signal transduction events. Can J Physiol Pharmacol, 72: 285-294.
Gonzalez, E.R. (1998) Antiplatelet therapy in atherosclerotic cardiovascular disease. Clinical Therapeutics, 20: B18-41,
Ginsberg, M.H., Xiaoping, D., O’Toole, T.E., Loftus, J.C. and Plow, E.F. (1993) Platelet integrins. Thromb Haemost, 87: 87–93.
George, J.N. (2000) Platelets. Lancet, 35: 1531-1539.
Hirazumi, A., Furusawa, E., Chou, S. and Hokama, Y. (1994) Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc West Pharmacol Soc, 37: 145-6.
Hiwasa, T., Arase, Y., Chen, Z., Kita, K, Umezawa, K., Ito, H. et al. (1999) Stimulation of ultraviolet-induced apoptos is of human fibroblast UVr-1 cells by tyrosine kinase inhibitors. FEBS Lett, 444: 173-6.
Hiramatsu, T., Imoto M., Koyano, T. and Umezawa, K. (1993) Induction of normal phenotypes in ras-trans formed cells by damnacanthal from Morinda citrifolia. Cancer Lett, 73: 161-6.
Jacob, S.W. and Herschler, R. (1986) Pharmacology of DMSO. Cryobiology
23, 14–27.
Jones, C.W., MSN, RNC, NNP. (2004) Platelet disorders. Newborn and Infant Nursing Reviews, 4 : 181–190
Kroll, M.H. and Schafer, A.I. (1989) Biochemical mechanisms of platelet activation. Blood, 74: 1181.1195.
Kamiya, K., Tanaka, Y., Endang, H., Umar, M. and Satake, T. (2004) Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation. J. Agric. Food Chem, 52: 5843-5848.
Liu, G., Bode, A., Ma, W.Y., Sang S., Ho, C.T., Dong, Z. (2001) Two novel glycos ides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell trans formation in the mouse epidermal JB6 cell line. Cancer Res, 61: 5749-56.
Libby, P., Ridker, P.M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation. 105: 1135–1143.
Levand, O. and Larson, H.O. (1979) Some chemical cons tituents of Morinda citrifolia. Planta Med. 36: 186-7.
Nelson, S.C. (2006) Morinda citrifolia (noni). Species Profiles for Pacific Island Agroforestry (www.traditionaltree.org): 1-19
Ojewole, J.A.O. and Adesina, S. K. (1983) Mechanism of the hypotensive effect of scopoletin isolated from the fruit of Tetrapleura tetraptera. Planta Med., 49(1): 46-50.
Plow, E.F., Haas, T.A., Zhang, L., Loftus, J. and Smith, J.W. (2000) Ligand binding to integrin. J. Biol. Chem, 275(29):21785-88.
Paul, B.Z.S., Jin, J. and Kunapuli, S.P. (1999) Molecular mechanism of thromboxane A2-induced platelet aggregation. J Biol Chem, 274: 29108–14.
Prescott, S.M., Zimmerman, G.A. and McIntyre, T.M. (1990) Platelet-activating factor. J Biol Chem, 265(29): 17381–17384.
Ramasamy, I. (2004) Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematol, 49: 1–35.
Raj, R.K. (1975) Screening of indigenous plants for anthelmintic action against humanAscaris Lumbricoides: Part-II. Indian J Physiol Pharmacol, 19: 47-9.
Ross, R. (1999) Atherosclerosis; an inflammatory disease. N Engl J Med., 340: 115–126.
Sang, S., Cheng, X., Zhu, N., Stark, R.E., Badmaev, V., Ghai G., Rosen R.T. and Ho C.T. (2001) Flavonol glycosides and novel iridoid glycoside from the leaves of Morinda citrifolia., J. Agric. Food Chem., 49: 4478-81.
Sheu, J.R., Hsiao, G., Shen, M.Y., Fong, T.H., Chen, Y.W., Lin, C.H. and Chou, D.S. (2002) Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br. J. Haematol., 119: 1033-1041.
Savage, B., Cattaneo, M. and Ruggeri, Z.M. (2001) Mechanisms of platelet aggregation. Curr. Opin. Hematol, 8: 270–276
Sang, S., He, K., Liu, G,, Zhu, N,, Cheng, X., Wang, M. et al. (2001)A new unusual iridoid with inhibition of activator protein-1 (AP-1) from the leaves of Morinda citrifolia L. Org Lett, 3: 1307-9.
Shapiro, A.D. (2000) Platelet function disorders. Haemophilia, 6: 120-127.
Teng, C.M., Li, H.L., Wu, T.S., Huang, S.C. and Huang, T.F. (1992) Antiplatelet actions of some coumarin compounds isolated from plant sources. Thrombosis Res., 66: 549–557.
Teng, C.M., Ko, F.N. and Yu, S.M. (1994) Inventory of exogenous factor affecting platelet aggregation isolated from plant sources. Thrombos. Haemostas. 71:517-519.
Teng, C.M. (2004) Biologically active agents isolated from chinase herbs and medicinal plants. J Chin Med., 15(3): 125-136.
Umezawa, K. (1992) Isolation of 1-methoxy-2-foremyl-3-hydroxyanthraquinone from M. citrifolia and neoplasm inhibitors containing the same. Japan Kokai Tokyo Koho JP 06 87, 736 (94-87, 736) Appl; 92/264, 311 07.
Vorchheimer, D.A. and Becker, R. (2006) Platelets in Atherothrombosis. Mayo Clin Proc., 81(1):59-68
Vargaftig, B.B., Chignard, M., Benveniste, J., Lefort, J. and Wal F. (1981) Background and present status of research on platelet-activating factor (PAF-acether). Ann. N. Y. Acad. Sci., 370: 119-137
Willoughby, S. Holmes, A. and Loscaizo, J. (2002) Platelets and cardiovascular disease. Eur J Cardiomsc Nurs., 1:273-288.
Wang, M.Y., West, B.J., Jensen, C.J., Nowicki, D., Chen, S.U., Palu, A.K. and Anderson, G. (2002) Morinda citrifolia (Noni): A literature review and recent advances in Noni research., Acta. Pharmacol. Sin., 23 (12): 1127-41,.
Yusuf, S. Hawken, S. Ounpuu, S. et al. (2004) INTERHEART Study Investigators. Effect of potentially moditiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART siudy): case-control study. Lancet. 364: 937-952.
Younos, C., Rolland A., Fleurentin, J., Lanhers, M.C., Miss, L.R. and Mortier, F. (1990) Analgesic and behavioural effects of Morinda citrifolia. Planta Med, 56: 430-4.
Yu, H., Li S., Huang, M.T. and Ho, C.T. (2004) Anti-inflammatory constituents in Noni (Morinda citrifolia) fruits. IFT Annual Meeting, 33F (28): 12-16
Zin, Z.M., Abdul-Hamid, A and Osman, A. (2002) Antioxidative activity of extracts from Mengkudu (Morinda citrifolia L.) root,fruit and leaf. Food Chem., 78: 227-231.